TRT Best Practices: Dosing, Monitoring, and Safety in 2026

Testosterone replacement therapy works best when it follows strict diagnostic protocols: two morning blood draws confirming total testosterone below 300 ng/dL, documented hypogonadal symptoms, and thorough baseline screening for prostate disease and cardiovascular risk. The difference between optimal TRT and mismanaged treatment comes down to formulation choice, dose titration to mid-normal levels (400–700 ng/dL), and structured monitoring for erythrocytosis and PSA velocity every three to six months.[1][2]

Modern guidelines from the Endocrine Society and American Urological Association emphasize that TRT is indicated for true hypogonadism, not vague "low energy" in aging men with borderline testosterone.[1][5] When prescribed appropriately, TRT improves libido, erectile function, body composition, bone density, and mood in many hypogonadal men.[1][3]

Diagnosis and baseline evaluation

Best-practice TRT begins with two separate fasting morning total testosterone measurements, ideally between 7 and 11 a.m., taken on different days.[1][2] The AUA defines testosterone deficiency as total testosterone consistently below 300 ng/dL (10.4 nmol/L), while the Endocrine Society uses approximately 264 ng/dL as the lower limit of normal.[1][2] Single measurements are unreliable due to diurnal variation and day-to-day fluctuation.

Men with altered sex hormone-binding globulin (SHBG) levels (obesity, diabetes, advanced age, liver disease) may need calculated or measured free testosterone for accurate diagnosis.[1] Measuring LH and FSH distinguishes primary testicular failure (elevated gonadotropins) from secondary hypothalamic-pituitary dysfunction (low or inappropriately normal gonadotropins), which guides workup for reversible causes such as hyperprolactinemia or pituitary adenomas.[1][2]

Baseline testing must include complete blood count to assess hemoglobin and hematocrit, prostate-specific antigen (PSA) in men over 40, and often lipid profile and HbA1c.[3][4][6] The Norfolk and Norwich University Hospitals guideline explicitly aims to maintain hematocrit below 50% on treatment, because erythrocytosis is the most common dose-dependent adverse effect.[4] PSA velocity greater than 1.4 µg/L per year or a rise exceeding 1 ng/mL over baseline warrants urological investigation.[4][6]

Men actively trying to conceive should not start TRT, because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and typically reduces sperm counts to zero within months.[1][6] Alternative approaches such as clomiphene citrate preserve fertility while supporting endogenous testosterone production; see our TRT vs Clomid analysis.

Formulation choice and dosing protocols

Injectable testosterone cypionate or enanthate remains the most widely used TRT modality due to low cost and flexible dosing. Current best practice favors weekly injections of 75–100 mg rather than 200 mg every two weeks, because more frequent lower doses minimize symptomatic peaks and troughs.[3][7] Monitoring serum testosterone midway between injections guides dose adjustments to maintain mid-normal levels.

Transdermal gels deliver 25–100 mg of testosterone daily, absorbed gradually through the skin to produce relatively steady-state levels.[3] The Norfolk guideline emphasizes measuring testosterone 4–6 hours after morning application to ensure accurate interpretation.[4] The primary practical concern is secondary transfer to women and children through skin contact; patients must wash hands after application and cover the application site with clothing.

"Switched from 200 mg cypionate every two weeks to 100 mg weekly and it completely flattened the rollercoaster. No more day-10 crash. Stable energy, stable mood, hematocrit stayed under 52%." — User report on r/Testosterone

Testosterone undecanoate offers an extra-long-acting injectable option (750 mg initially, a second dose four weeks later, then every ten weeks), producing stable serum levels.[3] Subcutaneous testosterone pellets (75 mg each, 2–6 pellets every three to six months) provide prolonged steady release and excellent adherence but require minor surgical procedures with each insertion.[3]

For cost and convenience comparisons across all TRT formulations, see our comprehensive TRT cost breakdown. Providers such as Peter MD and Hims offer telehealth TRT consultations, while Marek Health provides comprehensive hormone optimization. For in-person care, explore hormone therapy clinics or state-specific TRT services. Additional guidance is available in our testosterone treatment hub.

Frequently asked questions

What testosterone level qualifies you for TRT?

Testosterone replacement therapy requires two separate fasting morning blood draws showing total testosterone consistently below 300 ng/dL (10.4 nmol/L), according to the American Urological Association. The Endocrine Society uses approximately 264 ng/dL as the lower limit of normal for standardized assays. Both measurements should be taken between 7 and 11 a.m. on different days to account for diurnal variation and day-to-day fluctuation.

How often should you inject testosterone cypionate for TRT?

Current best practice favors weekly injections of 75–100 mg of testosterone cypionate rather than the older regimen of 200 mg every two weeks. More frequent lower doses minimize symptomatic peaks and troughs, providing more stable energy and mood throughout the treatment cycle. Dose adjustments typically occur in 25–50 mg increments based on mid-cycle testosterone measurements.

What labs should be monitored during TRT?

Patients on TRT should have hemoglobin, hematocrit, and PSA checked every three to six months to screen for erythrocytosis and prostate changes. The Norfolk and Norwich University Hospitals guideline explicitly aims to maintain hematocrit below 50% on treatment, because erythrocytosis is the most common dose-dependent adverse effect. PSA velocity greater than 1.4 µg/L per year or a rise exceeding 1 ng/mL over baseline warrants urological investigation.